Search results
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 5 days agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...
Carl June compares his new CAR T-cell therapy to 'an armored truck or tank' - Philadelphia Business...
The Business Journals· 5 days agoUniversity of Pennsylvania researchers presented phase 1 clinical trial of a new "armored" form of...
Health Beat: Do the benefits of CAR T-Cell therapy outweigh the risks?
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoIn 2017, the FDA approved the first CAR T-cell therapy. Medical experts call it a "breakthrough" and...
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 3 days agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 4 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Cancer Breakthrough: Scientists Discover Game-Changing New Type of T Cells
SciTechDaily· 2 days agoResearchers from the University of Houston identified CD8-fit T cells with high motility and serial...
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 6 days agoClinical-stage cell therapy company Shanghai Grit Biotechnology (GRIT) has formed a strategic...
Celularity reports advances in cancer T-cell therapy By Investing.com
Investing.com· 5 days agoCelularity Inc. (NASDAQ: CELU), a biotechnology firm specializing in regenerative medicine,...
Get Full Control Of Your T Cell Isolation For Your CAR T Cell Therapy Manufacturing
BioresearchOnline· 5 days agoCell therapies offer promising avenues for potentially treating malignancies that are currently...
Using Automated Spinoculation For CAR T Cell Lentiviral Transduction
BioresearchOnline· 1 day agoT cell therapies Kymriah™ from Novartis and Yescarta™ from Gilead/Kite underscores the increasing...